English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Rallis India mulls Rs 100-cr capex plan in FY 12qrcode

Jul. 5, 2011

Favorites Print
Forward
Jul. 5, 2011

Follow

 
Rallis India Ltd, a Tata Enterprise and a leading player in the Indian crop protection industry, has chalked out Rs 100-crore capital expenditure plan for the year FY 12.

"We will spend Rs 50-100 crore towards capital expenditure in the current fiscal. We are also launching 2-3 new products in the current year," Rallis Managing Director V Shankar told shareholders at the company's annual general meeting (AGM) here. Several new products are at various stages of development. Improvement plans for existing products are also underway with an objective of cost reduction and being competitive in the market, Shankar said.

The company has already registered 12 products in the international market. The company's Rs 180-crore Dahej facility in Gujarat becomes operational. This multi-purpose plant will enhance its competitive advantage to handle different type of chemistries, increasing the potential to attract contract manufacturing from suitable alliance partners. The production at Dahej facility will be mainly for international markets, Shankar said.
Source: ibnlive

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe India Special Biweekly to send news related to your mailbox